Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > Unique Low-Priced Gem Based on Fundamentals

<< Previous

Bullboard Posts

Next >>

Comment by MaterialWorldon Jul 07, 2020 5:19am

132 Views

Post# 31232325

RE:Unique Low-Priced Gem Based on Fundamentals

Great post cleareye. We're waiting for Q3 financial results. Hopefully Guy will be releasing updated info on how LBL Amnioboost Stem Cell research is going. We should be seeing a sharp increase in core product sales in Q3 NR. That will be the game changer and yes, $ 1.20 would not be an unreasonable share price. It's coming .............. MW

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?